ArticleAnnals of the rheumatic diseases2024

Pragmatic targets for moderate/severe SLE and their implications for clinical care and trial design: sustained DORIS or LLDAS for at least 6 months is sufficient while their attainment for at least 24 months ensures high specificity for damage-free progression.

Sofia Pitsigavdaki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.